tiprankstipranks
Sonova initiated with a Sell at Citi
The Fly

Sonova initiated with a Sell at Citi

Citi analyst Veronika Dubajova initiated coverage of Sonova with a Sell rating and CHF 220 price target. 2023 should see below-average revenue and earnings growth for the European health care services and medical technology group, with modestly improving surgical procedure volumes offset by consumer softness and above-average wage growth, Dubajova tells investors in a research note. Yet the analyst expects the sector to deliver revenue and earnings growth "meaningfully above" Citi strategists’ market expectations. Dubajova favors "quality growth that is resilient to macro headwinds" or where she sees meaningful mid-term sources of upside.

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles